Agilent Technologies, Inc. (A) Revenue by Segment

Agilent Technologies revenue by segment at a glance

In Q3 fiscal 2026 (the quarter ended July 31, 2026), Agilent Technologies's largest business segment was Agilent CrossLab, with $786.00 million or 42% of revenue, up 5.6% from a year earlier. Next: Life Sciences and Diagnostics Markets (40%) and Applied Markets (18%).

By product or service, Non-Instrumentation and Other brought in 66% and Instrumentation brought in 34% of revenue in Q3 fiscal 2026.

By region, Americas brought in 41%, Asia Pacific brought in 33% and Europe brought in 27% of revenue in Q3 fiscal 2026.

The fastest-growing business segment from a year earlier was Life Sciences and Diagnostics Markets (+11.3%).

From company filings, in USD; latest quarter ended July 31, 2026; quarterly data from Q1 fiscal 2018.

Agilent Technologies, Inc.

AHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Agilent CrossLabLife Sciences and Applied MarketsLife Sciences and Diagnostics MarketsDiagnostics and GenomicsApplied MarketsSegment Total

Q3 FY26 breakdown

Fiscal quarter ended Jul 31, 2026

Item	Revenue	Share	vs year before
Agilent CrossLab	USD 786.00M	41.9%	+5.6%
Life Sciences and Diagnostics Markets	USD 746.00M	39.7%	+11.3%
Applied Markets	USD 346.00M	18.4%	+6.8%

Sum of items USD 1.88B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18
Agilent CrossLab	786.0M	759.0M	758.0M	755.0M	744.0M	713.0M	696.0M	706.0M	691.0M	664.0M	686.0M	404.0M	396.0M	387.0M	381.0M	381.0M	359.0M	353.0M	359.0M	357.0M	343.0M	329.0M	331.0M	518.0M	463.0M	449.0M	470.0M	476.0M	467.0M	455.0M	442.0M	441.0M	–	–	–
Life Sciences and Applied Markets	–	–	–	–	–	–	–	–	–	–	–	928.0M	854.0M	874.0M	943.0M	739.0M	1.0B	896.0M	976.0M	962.0M	897.0M	881.0M	923.0M	671.0M	557.0M	526.0M	638.0M	622.0M	544.0M	529.0M	607.0M	597.0M	–	–	–
Life Sciences and Diagnostics Markets	746.0M	732.0M	679.0M	755.0M	670.0M	654.0M	647.0M	657.0M	585.0M	604.0M	620.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Diagnostics and Genomics	–	–	–	–	–	–	–	–	–	–	–	356.0M	422.0M	456.0M	432.0M	729.0M	340.0M	358.0M	339.0M	341.0M	346.0M	315.0M	294.0M	294.0M	241.0M	263.0M	249.0M	269.0M	263.0M	254.0M	235.0M	256.0M	–	–	–
Applied Markets	346.0M	344.0M	361.0M	351.0M	324.0M	301.0M	338.0M	338.0M	302.0M	305.0M	352.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Segment Total	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.2B	1.2B	1.2B

Agilent Technologies revenue by business segment, last 4 quarters

Business segment	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
Agilent CrossLab	$786.0M	$759.0M	$758.0M	$744.0M	42%
Life Sciences and Diagnostics Markets	$746.0M	$732.0M	$679.0M	$670.0M	40%
Applied Markets	$346.0M	$344.0M	$361.0M	$324.0M	18%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Agilent Technologies revenue by product or service, last 4 quarters

Product or service	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
Non-Instrumentation and Other	$1.2B	$1.2B	$1.1B	$1.1B	66%
Instrumentation	$643.0M	$618.0M	$658.0M	$599.0M	34%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Agilent Technologies revenue by region, last 4 quarters

Region	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
Americas	$761.0M	$764.0M	$678.0M	$683.0M	41%
Asia Pacific	$613.0M	$553.0M	$602.0M	$563.0M	33%
Europe	$504.0M	$518.0M	$518.0M	$492.0M	27%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Questions and answers

What are Agilent Technologies's business segments?

Agilent CrossLab, Life Sciences and Diagnostics Markets and Applied Markets (as reported for Q3 fiscal 2026).

Which business segment makes the most money for Agilent Technologies?

Agilent CrossLab: $786.00 million, or 42% of revenue, in Q3 fiscal 2026.

What are Agilent Technologies's main products and services?

By revenue in Q3 fiscal 2026: Non-Instrumentation and Other (66%) and Instrumentation (34%).

Where does Agilent Technologies make its money?

By region in Q3 fiscal 2026: Americas (41%), Asia Pacific (33%) and Europe (27%).

MoreAgilent Technologies stock overview Agilent Technologies financials Agilent Technologies executive team Agilent Technologies shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Agilent CrossLabLife Sciences and Applied MarketsLife Sciences and Diagnostics MarketsDiagnostics and GenomicsApplied MarketsSegment Total

Q3 FY26 breakdown

Fiscal quarter ended Jul 31, 2026

Item	Revenue	Share	vs year before
Agilent CrossLab	USD 786.00M	41.9%	+5.6%
Life Sciences and Diagnostics Markets	USD 746.00M	39.7%	+11.3%
Applied Markets	USD 346.00M	18.4%	+6.8%

Sum of items USD 1.88B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18
Agilent CrossLab	786.0M	759.0M	758.0M	755.0M	744.0M	713.0M	696.0M	706.0M	691.0M	664.0M	686.0M	404.0M	396.0M	387.0M	381.0M	381.0M	359.0M	353.0M	359.0M	357.0M	343.0M	329.0M	331.0M	518.0M	463.0M	449.0M	470.0M	476.0M	467.0M	455.0M	442.0M	441.0M	–	–	–
Life Sciences and Applied Markets	–	–	–	–	–	–	–	–	–	–	–	928.0M	854.0M	874.0M	943.0M	739.0M	1.0B	896.0M	976.0M	962.0M	897.0M	881.0M	923.0M	671.0M	557.0M	526.0M	638.0M	622.0M	544.0M	529.0M	607.0M	597.0M	–	–	–
Life Sciences and Diagnostics Markets	746.0M	732.0M	679.0M	755.0M	670.0M	654.0M	647.0M	657.0M	585.0M	604.0M	620.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Diagnostics and Genomics	–	–	–	–	–	–	–	–	–	–	–	356.0M	422.0M	456.0M	432.0M	729.0M	340.0M	358.0M	339.0M	341.0M	346.0M	315.0M	294.0M	294.0M	241.0M	263.0M	249.0M	269.0M	263.0M	254.0M	235.0M	256.0M	–	–	–
Applied Markets	346.0M	344.0M	361.0M	351.0M	324.0M	301.0M	338.0M	338.0M	302.0M	305.0M	352.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Segment Total	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.2B	1.2B	1.2B